Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.

Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

Glucagon-like peptide-1 receptor agonists (also known as GLP-1s), including medications like Ozempic, Mounjaro and Zepbound ... and Wegovy, appeared to reduce the risk of Alzheimer’s disease ...